These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23164420)

  • 1. Comment on thrombotic microangiopathy induced by interferon-β therapy.
    Cavoli GL; Passantino R; Tortorici C; Bono L; Ferrantelli A; Rotolo U
    Clin Nephrol; 2012 Dec; 78(6):506-7. PubMed ID: 23164420
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombotic microangiopathy induced by long-term interferon-β therapy for multiple sclerosis: a case report.
    Broughton A; Cosyns JP; Jadoul M
    Clin Nephrol; 2011 Nov; 76(5):396-400. PubMed ID: 22000560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal thrombotic microangiopathy caused by interferon beta-1a treatment for multiple sclerosis.
    Mahe J; Meurette A; Moreau A; Vercel C; Jolliet P
    Drug Des Devel Ther; 2013; 7():723-8. PubMed ID: 23950639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-beta in multiple sclerosis causing thrombotic microangiopathy.
    Yam C; Fok A; Mclean C; Butler E; Kempster P
    Intern Med J; 2019 Feb; 49(2):274-276. PubMed ID: 30754081
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interferon ß, nephrotic syndrome and thrombotic microangiopathy].
    Quintana LF; Campistol JM
    Med Clin (Barc); 2015 Jan; 144(2):65-6. PubMed ID: 25458512
    [No Abstract]   [Full Text] [Related]  

  • 6. The Case | The young philosopher with multiple sclerosis and proteinuria.
    Piccoli GB; Capobianco M; Vigotti FN; Naretto C; Narioz C; Brocheriou I; Roccatello D
    Kidney Int; 2016 Apr; 89(4):961-3. PubMed ID: 26994580
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombotic microangiopathy associated with interferon beta.
    Hunt D; Kavanagh D; Drummond I; Weller B; Bellamy C; Overell J; Evans S; Jackson A; Chandran S
    N Engl J Med; 2014 Mar; 370(13):1270-1. PubMed ID: 24670186
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrombotic microangiopathy due to acquired complement factor I deficiency in a male receiving interferon-beta treatment for multiple sclerosis.
    Mrabet S; Dahmane R; Raja B; Fradi A; Aicha NB; Sahtout W; Azzabi A; Guedri Y; Zellama D; Achour A; Sfar I; Goucha R; Abdessayed N; Mokni M
    Br J Clin Pharmacol; 2023 May; 89(5):1682-1685. PubMed ID: 36480744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic microangiopathy and accelerated hypertension after treatment with interferon beta.
    Pérez EP; Sánchez de la Nieta García MD; López LG; Hernández FR
    Nefrologia (Engl Ed); 2018; 38(5):564-565. PubMed ID: 29433840
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoimmune hepatitis and interferon beta-1a for multiple sclerosis.
    Duchini A
    Am J Gastroenterol; 2002 Mar; 97(3):767-8. PubMed ID: 11922585
    [No Abstract]   [Full Text] [Related]  

  • 11. An open labelled assessment of adverse effects associated with interferon 1-beta in the treatment of multiple sclerosis.
    Ozuma J
    J Neurosci Nurs; 1996 Apr; 28(2):72. PubMed ID: 8718753
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombotic Microangiopathy Presenting with Intestinal Involvement Following Long-term Interferon-β1b Treatment for Multiple Sclerosis.
    Omoto S; Utsumi T; Matsuno H; Terasawa Y; Iguchi Y
    Intern Med; 2018 Mar; 57(5):741-744. PubMed ID: 29151517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hepatitis secondary to interferon beta-1a in multiple sclerosis.
    Christopher V; Scolding N; Przemioslo RT
    J Neurol; 2005 Jul; 252(7):855-6. PubMed ID: 15742101
    [No Abstract]   [Full Text] [Related]  

  • 14. [Appearance of immune thyroid diseases during beta-interferon therapy of multiple sclerosis].
    Buchinger W; Niederwieser G; Rainer F
    Dtsch Med Wochenschr; 1999 Dec; 124(48):1473. PubMed ID: 10615332
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon beta retinopathy in a patient with multiple sclerosis.
    Post JW; Colleaux K
    Can J Ophthalmol; 2009 Oct; 44(5):e37. PubMed ID: 19798812
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of myasthenia gravis in two patients with multiple sclerosis following interferon beta treatment.
    Dionisiotis J; Zoukos Y; Thomaides T
    J Neurol Neurosurg Psychiatry; 2004 Jul; 75(7):1079. PubMed ID: 15201386
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythema elevatum et diutinum, multiple sclerosis and interferon beta.
    Gil M; Chizzolini C; Kaya G; Hauser C
    Dermatology; 2004; 209(1):75-6. PubMed ID: 15237277
    [No Abstract]   [Full Text] [Related]  

  • 18. Subacute thyroiditis in a patient with MS treated with interferon beta-1a.
    Kreiss Y; Cohen O; Pras E; Achiron A
    Neurology; 1999 Oct; 53(7):1606. PubMed ID: 10534282
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: a case report.
    Kocer B; Nazliel B; Oztas M; Batur HZ
    Eur J Neurol; 2009 Apr; 16(4):e78-9. PubMed ID: 19222549
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver and thyroid function and autoimmunity during interferon-beta 1b treatment for multiple sclerosis.
    Tremlett H
    Neurology; 2002 Jun; 58(12):1868. PubMed ID: 12084903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.